» Authors » Helen M Colhoun

Helen M Colhoun

Explore the profile of Helen M Colhoun including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 188
Citations 8733
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetologia . 2025 Feb; PMID: 39934371
No abstract available.
2.
Badve S, Bilal A, Lee M, Sattar N, Gerstein H, Ruff C, et al.
Lancet Diabetes Endocrinol . 2024 Nov; 13(1):15-28. PMID: 39608381
Background: GLP-1 receptor agonists reduce the risk of major adverse cardiovascular events (MACE) and can also have kidney benefits. However, whether GLP-1 receptor agonists improve clinically important kidney outcomes remains...
3.
Roshandel D, Spiliopoulou A, McGurnaghan S, Iakovliev A, Lipschutz D, Hayward C, et al.
Diabetes . 2024 Nov; 74(2):223-233. PMID: 39556808
Identified genetic loci for C-peptide and type 1 diabetes (T1D) age at diagnosis (AAD) explain only a small proportion of their variation. We aimed to identify additional genetic loci associated...
4.
Magliano D, Chen L, Morton J, Salim A, Carstensen B, Gregg E, et al.
Lancet Diabetes Endocrinol . 2024 Nov; 12(12):915-923. PMID: 39541997
Background: Population-based incidence data on young-adult-onset type 1 diabetes and type 2 diabetes are limited. We aimed to examine secular trends in the incidence of diagnosed type 1 diabetes and...
5.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetes Care . 2024 Sep; 47(11):2033. PMID: 39240700
No abstract available.
6.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetologia . 2024 Sep; 67(9):2012-2014. PMID: 39230637
No abstract available.
7.
Verma S, Colhoun H, Dicker D, Hovingh G, Kahn S, Kautzky-Willer A, et al.
J Am Coll Cardiol . 2024 Sep; 84(17):1678-1682. PMID: 39217575
No abstract available.
8.
Deanfield J, Verma S, Scirica B, Kahn S, Emerson S, Ryan D, et al.
Lancet . 2024 Aug; 404(10454):773-786. PMID: 39181597
Background: Semaglutide, a GLP-1 receptor agonist, reduces the risk of major adverse cardiovascular events (MACE) in people with overweight or obesity, but the effects of this drug on outcomes in...
9.
Mellor J, Kuznetsov D, Heller S, Gall M, Rosilio M, Amiel S, et al.
Diabetologia . 2024 Jul; 67(10):2210-2224. PMID: 39037602
Aims/hypothesis: Whether hypoglycaemia increases the risk of other adverse outcomes in diabetes remains controversial, especially for hypoglycaemia episodes not requiring assistance from another person. An objective of the Hypoglycaemia REdefining...
10.
Aizawa K, Hughes A, Casanova F, Gooding K, Gates P, Mawson D, et al.
ESC Heart Fail . 2024 Jul; 11(5):3290-3298. PMID: 38946623
Aims: Parameters derived from reservoir-excess pressure analysis have been demonstrated to predict cardiovascular events. Thus, altered reservoir-excess pressure parameters could have a detrimental effect on highly-perfused organs like the heart....